{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:58:49Z","timestamp":1790351929105,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515110036"],"award-info":[{"award-number":["2023A1515110036"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403321"],"award-info":[{"award-number":["82403321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"publisher","award":["2023B03J1291"],"award-info":[{"award-number":["2023B03J1291"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejphar.2024.177230","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T07:11:09Z","timestamp":1735197069000},"page":"177230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The phosphodiesterase-4 inhibitor Zl-n-91 suppresses glioblastoma growth via EGR1\/PTEN\/AKT pathway"],"prefix":"10.1016","volume":"988","author":[{"given":"Yuyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiri","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenggang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan Z.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177230_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109686","article-title":"Piclamilast mitigates 1,2-dimethylhydrazine induced colon cancer in rats through modulation of Ras\/PI3K\/Akt\/mTOR and NF-\u03ba\u03b2 signaling","volume":"350","author":"Abdel-Wahab","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2024.177230_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","article-title":"Challenges to curing primary brain tumours","volume":"16","author":"Aldape","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2024.177230_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors","volume":"16","author":"Ashkenazi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.177230_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.cgt.7700896","article-title":"The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin","volume":"13","author":"Baron","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ejphar.2024.177230_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.canlet.2017.06.031","article-title":"p27 Kip1 and human cancers: a reappraisal of a still enigmatic protein","volume":"403","author":"Bencivenga","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2024.177230_bib6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/neuonc\/noad143","article-title":"CDK7 and CDK9 inhibition interferes with transcription, translation, and stemness, and induces cytotoxicity in GBM irrespective of temozolomide sensitivity","volume":"26","author":"Bhutada","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejphar.2024.177230_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1073\/pnas.1008848108","article-title":"Egr1 mediates p53-independent c-Myc\u2013induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism","volume":"108","author":"Boone","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2024.177230_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00571-x","article-title":"PTEN suppresses tumorigenesis by directly dephosphorylating Akt","volume":"6","author":"Bu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2024.177230_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-4-1","article-title":"Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma","volume":"4","author":"Calogero","year":"2004","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2024.177230_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00016","article-title":"The host cell transcription factor EGR1 is induced by bacteria through the EGFR\u2013ERK1\/2 pathway","volume":"7","author":"de Klerk","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejphar.2024.177230_bib11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4155\/fmc-2023-0101","article-title":"PDE4 inhibitors for disease therapy: advances and future perspective","volume":"15","author":"Du","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177230_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1407871","article-title":"PDE4 inhibitors: potential protective effects in inflammation and vascular diseases","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177230_bib13","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/acs.biochem.8b00336","article-title":"Identification of a PDE4-specific pocket for the design of selective inhibitors","volume":"57","author":"Feng","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2024.177230_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.01.004","article-title":"FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP\/PS1 transgenic mice via cAMP\/PKA\/CREB signaling and anti-inflammatory effects","volume":"116","author":"Guo","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.177230_bib15","first-page":"3","article-title":"Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment","volume":"18","author":"Hanif","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ejphar.2024.177230_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114204","article-title":"Progress in targeting PTEN\/PI3K\/Akt axis in glioblastoma therapy: revisiting molecular interactions","volume":"158","author":"Hashemi","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177230_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2024.177230_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411518","article-title":"PDE4 inhibitors: profiling hits through the multitude of structural classes","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177230_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbrc.2018.12.004","article-title":"Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer","volume":"508","author":"Kim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.177230_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2014.03.025","article-title":"EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer","volume":"349","author":"Kim","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2024.177230_bib21","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Ki67 is a promising molecular target in the diagnosis of cancer","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2024.177230_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810616","article-title":"The complexity and multiplicity of the specific cAMP phosphodiesterase family: PDE4, open new adapted therapeutic approaches","volume":"23","author":"Lugnier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177230_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158052","article-title":"PDE4D: a multipurpose pharmacological target","volume":"25","author":"Lusardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177230_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228658","article-title":"Influence of phosphodiesterase inhibition on CRE- and EGR1-dependent transcription in a mouse hippocampal cell line","volume":"21","author":"Maronde","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177230_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121511","article-title":"Targeting cyclic AMP signalling in hepatocellular carcinoma","volume":"8","author":"Massimi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177230_bib26","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jcb.30325","article-title":"PDE4 inhibitor eliminates breast cancer stem cells via noncanonical activation of mTOR","volume":"123","author":"Mukherjee","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2024.177230_bib27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1389450120666190618123846","article-title":"PI3K\/akt\/mTOR pathway as a therapeutic target for colorectal cancer: a review of preclinical and clinical evidence","volume":"20","author":"Narayanankutty","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2024.177230_bib28","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejphar.2024.177230_bib29","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1080\/15548627.2023.2242696","article-title":"Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate","volume":"19","author":"Ou","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2024.177230_bib30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/pharmrev.120.000273","article-title":"The molecular Biology of phosphodiesterase 4 enzymes as pharmacological targets: an interplay of isoforms, conformational states, and inhibitors","volume":"73","author":"Paes","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2024.177230_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116880","article-title":"Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model","volume":"239","author":"Ramezani","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2024.177230_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113125","article-title":"Novel cyanothiouracil and cyanothiocytosine derivatives as concentration-dependent selective inhibitors of U87MG glioblastomas: adenosine receptor binding and potent PDE4 inhibition","volume":"212","author":"Sahin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.177230_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.tips.2011.02.015","article-title":"Treating brain tumors with PDE4 inhibitors","volume":"32","author":"Sengupta","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2024.177230_bib34","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1139\/cjpp-2017-0035","article-title":"cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells","volume":"95","author":"Simo-Cheyou","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177230_bib35","article-title":"The influence of cell cycle regulation on chemotherapy","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177230_bib36","article-title":"The role of the transcription factor EGR1 in cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2024.177230_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jnutbio.2015.02.008","article-title":"EGR-1\/Bax pathway plays a role in vitamin E \u03b4-tocotrienol-induced apoptosis in pancreatic cancer cells","volume":"26","author":"Wang","year":"2015","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2024.177230_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104963","article-title":"Glioblastoma vaccines: past, present, and opportunities","volume":"100","author":"Xiong","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejphar.2024.177230_bib39","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11011-022-00925-6","article-title":"METTL7B contributes to the malignant progression of glioblastoma by inhibiting EGR1 expression","volume":"37","author":"Xu","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2024.177230_bib40","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8579","article-title":"Lentinan induces apoptosis of mouse hepatocellular carcinoma cells through the EGR1\/PTEN\/AKT signaling axis","volume":"50","author":"You","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2024.177230_bib41","article-title":"Roflumilast inhibits tumor growth and migration in STK11\/LKB1 deficient pancreatic cancer","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.ejphar.2024.177230_bib42","first-page":"1911","article-title":"CDK2 and CDK4: cell cycle functions evolve distinct","volume":"4","author":"Zhang","year":"2024","journal-title":"Catalysis-Competent Conformations, Offering Drug Targets. JACS Au"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924009208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T10:16:26Z","timestamp":1742033786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924009208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"alternative-id":["S0014299924009208"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177230","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phosphodiesterase-4 inhibitor Zl-n-91 suppresses glioblastoma growth via EGR1\/PTEN\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177230"}}